Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8789982 | Urologic Oncology: Seminars and Original Investigations | 2018 | 11 Pages |
Abstract
The selected articles (17) demonstrate the involvement of MMP-9 as a modulator of bone metastatic lesions either of osteoblast, osteoclast or mixed origin as well as the recognition of the major mechanisms or molecules involved in the regulation of expression gene of MMP-9 and finally establishing the MMP-9 as a therapeutic target for possible future drug development. Finally, this study evidences MMP-9 as an essential factor for the activation of the chain of the different MMPs and consequently in the genesis and development of bone metastasis of PCa due to its influence on bone osteoblastic and osteoclastic activity.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Emilio Rubén M.Sc., Isaac Ph.D., MarÃa Jesús Ph.D.,